---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-22-037226"
form_type: "8-K/A"
ticker: "LSTA"
cik: "0000320017"
company_name: "LISATA THERAPEUTICS, INC."
filed_at: "2022-10-14T23:59:59+00:00"
generated_at: "2026-06-23T03:40:46.794722+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Lisata files audited FY2020-2021 financials of acquired Cend Therapeutics

## Summary
- Audited financial statements of Cend for FY2020 and FY2021 filed as Exhibit 99.1.
- Consent of independent auditor WithumSmith+Brown, PC filed as Exhibit 23.1.
- This amendment fulfills the remaining financial statement requirements for the September 2022 merger.
- No other changes were made to the initial Form 8-K reporting the merger completion.

## SEC filing metadata
- accession: 0001140361-22-037226
- form_type: 8-K/A
- ticker: LSTA
- cik: 0000320017
- company_name: LISATA THERAPEUTICS, INC.
- filed_at: 2022-10-14T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/320017/000114036122037226/0001140361-22-037226-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/320017/000114036122037226/brhc10042873_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-22-037226
- JSON: https://secwatch.observer/filing/0001140361-22-037226.json
- Plain text: https://secwatch.observer/filing/0001140361-22-037226.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.